Now is a great time to add Khiron (TSXV:KHRN) to your portfolio
Khiron Life Sciences (TSXV: KHRN) is growing: recently, Chris Naprawa, President of KHRN, sent me some pictures from their grow facility in Colombia. These pictures show how well things are progressing in Colombia. The picture above shows the construction of a building adjacent to the grow facility. The two pictures below show healthy plants in the grow facility nearing maturity. This two story building is constructed to GMP standards and will house extraction facilities and laboratories as well as packaging and shipping. The capacity within the building exceeds current requirements. The plan is to do everything on site to avoid having to ship unnecessary biomass. Remember, KHRN’s business as planned at present is the production of pharmaceutical grade medical marijuana products.
The acquisition of ILANS ensured revenue at a base level of $10 to $12 million. These pictures indicate product sales will add to that number as will revenue from the sale of Kuida products. If for some inexplicable reason you are a regular reader of the Let’s Toke Business newsletter and you don’t yet own KHRN, this is a great time to add it to your portfolio.